Literature DB >> 12662101

Anti-inflammatory constituents and new pterocarpanoid of Crotalaria pallida.

Jing-Ru Weng1, Lo-Ti Tsao, Ming-Hong Yen, Jih-Pyang Wang, Chun-Nan Lin.   

Abstract

One new pterocarpanoid, crotafuran E (1), and three known compounds were isolated from the bark of Crotalaria pallida. The structure of 1 was determined by spectral methods. Two pterocarpanoids, crotafurans A (2) and B (3), previously isolated from this plant, showed significant concentration-dependent inhibitory effects on the NO production in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage-like cells, with IC(50) values of 23.0 +/- 1.0 and 19.0 +/- 0.2 microM, respectively. Compound 3 also inhibited the LPS/interferon-gamma (IFN-gamma)-stimulated NO production in N9 microglial cells with an IC(50) value of 9.4 +/- 0.9 microM. Moreover, compound 2 produced a concentration-dependent inhibition of the release of beta-glucuronidase and lysozyme from rat neutrophils in response to formyl-Met-Leu-Phe/cytochalasin B (fMLP/CB) with IC(50) values of 7.8 +/- 1.4 and 9.5 +/- 2.1 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662101     DOI: 10.1021/np020135d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  In-vivo study of tissue reaction to Crotalaria pallida and Sansevieria roxburghiana fibers.

Authors:  Sahana Kamath; Muralidhara Sharma; B Ravishankar; Ravi Mundugaru
Journal:  J Ayurveda Integr Med       Date:  2017-06-07

2.  Antibiotic Isoflavonoids, Anthraquinones, and Pterocarpanoids from Pigeon Pea (Cajanus cajan L.) Seeds against Multidrug-Resistant Staphylococcus aureus.

Authors:  Lex Aliko P Balida; Julia Theresa A Regalado; Jade Joshua R Teodosio; Kathryn Ann H Dizon; Zhe Sun; Zhao Qi Zhan; Jenny Marie D Blancaflor; Jan Vincent N Sollesta; Zenith M Villorente; Jonel P Saludes; Doralyn S Dalisay
Journal:  Metabolites       Date:  2022-03-23

3.  Estrogenic and mutagenic activities of Crotalaria pallida measured by recombinant yeast assay and Ames test.

Authors:  Paula Boldrin; Flávia Resende; Ana Höhne; Mariana de Camargo; Lívia Espanha; Catarine Nogueira; Maria Melo; Wagner Vilegas; Eliana Varanda
Journal:  BMC Complement Altern Med       Date:  2013-09-04       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.